All In Biotech

Drug Trial Radar · NCT07145346

Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures

Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures: A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

80

Planned (sponsor's estimate)

Start

Nov 13, 2025

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
University of California, IrvineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Rib fractures cause a significant amount of pain and are associated with an increased risk of lung infections, long hospitalization, and increased cost. Effective pain control is the cornerstone of management to improve lung function and minimize complications. Most often this is done with a multimodal pain routine consisting of: acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), topical lidocaine, muscle relaxants, and opioids. However, suzetrigine is a promising alternative to treat acute pain associated with rib fractures. We think the addition of suzetrigine to a multimodal pain regimen will improve pain and decrease opioid use.

Conditions

  • Rib Fractures

Interventions

  • Suzetrigine (SUZ)Drug

    The intervention arm will receive oral suzetrigine (100 mg loading dose followed by 50 mg every 12 hours).

  • PlaceboDrug

    The control arm will receive placebo capsules matched to suzetrigine for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of PainTime frame: Through study completion of index hospitalization (up to 2 years)
  2. Use of morphine and morphine equivalentsTime frame: Through study completion of index hospitalization (up to 2 years)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California, Irvine

    Orange, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.